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ABSTRACT OF THE THESIS 
Survival Analysis of Cardiovascular Diseases 
by 
Yuanxin Hu 
Master of Arts in Statistics 
Washington University in St. Louis, 2013 
Professor Ed Spitznagel, Chair 
Cardiovascular disease (CVD) is a class of diseases related to the heart or blood vessels. It is the leading 
cause of death worldwide. Many risk factors are found to be associated with it, such as family history, 
gender, age, etc. Much effort has been paid to identify them and to evaluate their effects on the onset or 
progression of the diseases, so that prediction of onset/development of the diseases can be made, and 
preventive solutions can be applied.  
Thus far, much survival analysis of cardiovascular diseases comes from relatively collected populations 
followed over short time, and the findings may not easily be generalized to the patients. The current data 
set is one subset of data collected by The Framingham Heart Study since 1948, which recorded 5209 
subjects originally. Current data includes 4434 randomly selected subjects living in the community of 
Framingham. 
The main goal for our current study is to build up a Cox proportional hazards model by survival analysis 
using the SAS statistical package. To process the analysis, the proportional assumption or time 
dependence for individual factors is tested; variables are selected; and their interactions are considered to 
optimize the model. Due to strikingly impact of gender on the prediction, it is stratified. Therefore different 
baseline hazards are applied for the set of variables within each group.   
In the model, the parameters are estimated by maximum likelihood Newton-Raphson algorithm. The 
results show that gender, status of diabetes, age, body mass index, cholesterol and blood pressure are 
v 
found impacting the diseases onset/development. Interestingly, the education level has its influence on it 
as well.  
1 
Introduction 
Cardiovascular Diseases 
Heart is the organ pumping blood through the blood vessels and arteries to all parts of the body. In the 
process, it delivers oxygen and nutrients through the whole body, and also collects waste products and 
gets rid of them from it [1]. The process is vital for life. The cardiovascular system includes the heart and 
all the network of blood vessels. Diseases or disorders related to the system are termed cardiovascular 
diseases (CVD), such as Coronary heart disease, congenital heart disease, stroke or cerebrovascular 
accident (CVA), congestive heart failure, peripheral arterial disease or peripheral vascular diseases, deep 
venous thrombosis (DVT) and pulmonary embolism, rheumatic heart disease, and other cardiovascular 
diseases caused by tumors of the heart [2, 3, 4, 5].  But the major CVD are heart attacks and strokes. 
Cardiovascular diseases are the leading causes of death worldwide, which killed over 17 million people in 
2008. They have been prevailing in developed countries, but they are becoming severe issues for the 
people living in developing countries as well since decades ago [6, 7]. 
Risk Factors 
CVD is very common in population, especially for adults [7]. Some risks are found contributing lots to the 
onset or progression of the disease, such as age, gender, genetics, lifestyles, and some biochemistry 
parameters of the body [8, 9]. They are categorized as uncontrollable factors, such as age, sex and family 
history [10, 11, 12], and modifiable factors, such as lifestyles and other biochemistry parameters. For 
example, people can delay the onset or development of the diseases by changing their lifestyles, such as 
excises, no smoking, healthy diets [13, 14, 15, 16]. Consequently, the biochemistry parameters can be 
improved as well with healthy lifestyle, which will decrease the risk of suffering from the diseases [17, 18].  
Blood pressure is a well-known risk factor for cardiovascular diseases. Once it reaches and keeps at high 
level of blood pressure, sooner or later, the people will develop cardiovascular diseases. And it is 
irreversible after a period. In theory, higher blood pressure makes heart work harder to pump blood out of 
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it. As a result, the wall of heart will be thickening at the beginning, and then be thinner and thinner 
gradually later. Eventually, the wall of heart will be too thin to contract powerfully, so the pressure in the 
heart becomes higher and higher until it is out of control [20, 21, 22].  
Cholesterol is a fatty wax-like substance found in the blood. Reasonable concentration of cholesterol in 
the blood is crucial for keeping good health. There are two common lipoproteins called high-density 
lipoproteins (HDL) and low-density lipoproteins (LDL). The HDL carries extra fat away from arteries, so 
that extra fat will not accumulate in them. However, the LDL assists fat to build up on the artery wall. The 
deposited fat will shrink space of artery. Eventually, it leads to high blood pressure. The normal level of 
total cholesterol for adults is below 200. The risk of heart attack increases dramatically with its 
concentration goes high[18, 23]. 
Smoking is another well-known risk factor. In principle, nicotine narrows the blood vessels and causes 
high blood pressure and high heart rate. In addition, the byproduct of smoking carbon monoxide 
competes with oxygen in the red blood cells so less oxygen can be delivered to the heart. As a 
consequence, it damages artery wall. In addition, it involves in more damages in heart than that, such as, 
depositing cholesterol in artery and reducing blood HDL level. As reported, smoking can increase twice 
risk of early death from heart attack as nonsmokers [24, 25]. 
Diabetes is due to dysfunction of response to insulin, which results in high blood sugar level. It also brings 
up the accumulation of lipoprotein and increases atherosclerosis as side effect. Usually, Diabetes 
combines with high blood pressure, high cholesterol, low level of HDL, and overweight (obesity). Any 
individual of those factors contributes the progression or onset of heart failure, and the combination has 
cumulative effect on the diseases [21, 22]. 
Stress is a part of our lives. It is another controllable risk factor. During dealing with tough situation, the 
body releases chemicals, such as adrenalin, which can narrow blood vessels, and cause high blood 
pressure [26]. People experiencing long-period pressure are prone to coronary artery disease.  
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Age, sex and family history (genetic heredity) are uncontrollable risk factors. Aging is associated with 
progressive decline in numerous physiological processes and fundamental morphological and structural 
changes of heart. Specifically, aging results in dysfunction of endothelium, which leads death and decline 
of heart endothelial cells [11, 12]. In clinic, the dysfunction results in high blood pressure and increases 
risk for development of atherosclerosis, hypertension, stroke and arterial fibrillation. 
Certain genetic mutations can raise the likelihood of having heart and vascular diseases. And its risk can 
be told by family history. As report, subjects most likely bear genetic mutations of risks, if their close 
relative has had heart diseases at certain age, for example, 55 years for male, 65 years old for female 
[27,28]. They inherit higher tendency toward heart disease than people who do not have family history of 
CVD.  
Interestingly, sex is found to be a critical risk factor of CVD, since men are more likely to have heart and 
blood vessel problems at an earlier than women, especially before menopause. As report, estrogen may 
play critical role in the prevention. As known, estrogen can up-regulate HDL, which is good for health of 
heart [11].  
The above generally gives an introduction of the risk factors individual by individual, but they are working 
separately. The impacts can be cumulative, or enhancive on development of the diseases, so all the risk 
factors should be considered interactively or in an integrative way. Therefore, it would be meaningful to 
build up a system or model with consideration of all potential risks. And then, the effective prediction or 
evaluation of risks can be made, and suggestions and treatments can be applied for prevention or delay 
the disease onset or progression.  
Risk Scoring Systems and Models 
Due to high incidence and cost of the CVD, to predict the risk of cardiovascular events is important. It will 
assist clinical practice guidelines target primary prevention and recommend that providers evaluate 
patients for cardiac risk factors that warrant medical treatment. 
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Thus far, several scoring systems to evaluate the risk of suffering from CVD have been developed, such 
as the Framingham Scoring System (FSS)[30], Joint British Societies (JBS) [31] and ASSIGN [32, 33]. In 
general, the systems assign certain scores for individual risk factors. The risk of suffering from 
cardiovascular disease is evaluated with the calculated sum of the scores.  The higher the score means 
greater risk. Among them, the FSS is the most popular one. Others followed similar ideas and scales for 
individual risks, but introduced specific criteria or scores for specific populations. The Framingham system 
can be applied for evaluation of risks of several CVD outcomes with period range 4 to 12 years, such as 
stroke, coronary disease, myocardial infarction, and death from either coronary or cardiovascular disease 
[30, 31, 32, 33, 34, 35].  
The JBS has developed its own guideline called British National Formulary (BNF) for evaluation of 
cardiovascular risk, but mainly for risk of coronary disease stroke. It inherits scoring rules and scales used 
by FSS [34, 35]. Either FSS or JBS has limitation of generalization for all populations, The ASSIGN 
scoring system was developed in conjunction with the Scottish Intercollegiate Guidelines Network by 
introducing more risk factors, such as family history and social deprivation [32, 33]. It serves well for 
Scottish population. 
In general, all the systems treat age as a dominated factor during evaluation [34]. Certainly, it can be a 
limitation or problem, because the risk for healthy older people might be higher than that of younger CVD 
patients evaluated by the systems. Since all preventive treatments or benefits are designed for high-risk 
population, the actual high-risk young patients may be ignored. Therefore, the existing scoring system 
can be improved [37, 38, 39, 40]. 
In addition, the accuracy of evaluation of the risk is not always satisfactory, because the impacts of risk 
factors on different populations and different individuals within same population vary greatly. They can be 
different also among races, types of diseases, and so on. Thus far, the systems can only evaluate risks 
for particular heart diseases. For example, the FSS can only predict the risk event for coronary disease. 
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Others are beyond its capability [41, 42, 43, 44, 45, 46]. And also, all the prediction can only be applied 
for subjects at certain ages.  
Until now, over hundred other risk models for prediction of cardiovascular risk have been developed, such 
as Framingham (FRS) model for CVD, the Prospective Cardiovascular Munster (PROCAM) model for 
CHD, and the Systematic Coronary Risk Evaluation (SCORE) model for CVD mortality. Unfortunately, 
only a few of them have been validated for various times and different cohorts, such as Scottish Heart 
Health Extended Cohort (SHHEC), Diabetes Audit and Research in Tayside, Scotland (DARTS), 
FINRISK, Framingham Study (FRS), Framingham Offspring Study (FRS-O), Prospective Cardiovascular 
Munster Study (PROCAM), QRESEARCH Database, Systematic Coronary Risk Evaluation (SCORE) and 
United Kingdom Prospective Diabetes Study (UKPDS) [46, 47, 48, 49]. These systems are improved at 
some points, but the above limitations still exist among them. 
Survival Data and Survival Analysis 
Survival data is collected for investigation of time to event. The event can be death, occurrence of 
disease, machine failure or end of marriage, and so on [50]. One common characteristic of survival data 
is censoring, truncation, or combination of censoring and truncation, due to end of investigation, drop out 
of subjects, or even the experiment design with threshold. Therefore, the information for the censored or 
truncated subjects is not complete known. Certainly, the presence of censoring or truncation of data 
requires special treat during data analysis, for example, with consideration of both time to event and 
indication of censoring together, since it may not properly by treating the data by classical way. For 
example, simply evaluation of mean time to event among groups using t-test or linear regression ignores 
censoring issues, whose information is not completely known. Or, comparison of proportion of events 
among groups using risk/odds ratio test or logistic regression does not take account of impact of time. 
Therefore, the analysis should consider both of them. For example, to count the likelihood function, the 
terms corresponding to both observed data and censored data should be considered together. For 
observed data, it contributes to its density function at time t, while the censored observation accounts for 
the probability function over time t. Fortunately, the occurrence of censoring is not related to the future 
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time, for example, the probability distribution of residual lifetime is not different between censored 
observations and uncensored cases, since they bear same set of explanatory variables [53, 54].  
Data 
Current investigation includes a subset of data for the Framingham Heart Study. It is a long term 
prospective study of etiology of cardiovascular disease among population living in the community of 
Framingham, Massachusetts. The data set was collected with 5209 subjects enrolled initially since 1948. 
The participants have been examined biennially and continuously followed through regular surveillance 
for cardiovascular outcomes. Clinic examinations has included with cardiovascular disease risk factors 
and markers of disease, such as blood pressure, blood chemistry, lung function, smoking history, health 
behaviors, ECG tracing, Echocardiography, and use of medications. Through regular surveillance, the 
study reviews and adjudicates events for occurrence of Angina Pectoris, Myocardial Infarction, Heart 
failure, and cerebrovascular disease. 
The current dataset includes 4434 participants with three examination periods, approximately 6 years 
apart from 1956 to 1968. The data set includes information of laboratory results, clinic diagnostics, 
healthy questionnaire, and adjudicated events. Each participant was followed for a total 24 years for 
outcome of the events, such as Angina Pectoris, Myocardial Infarction, Atherothrombotic Infarction or 
Cerebral hemorrhage (Stroke), or death. 
The data set is provided in longitudinal form. Each participant has 1 to 3 observations depending on the 
exams the subject attended. Overall, there are 11,627 observations on the 4434 participants. For 
example, the participant with RANDID 95148 had three exams (period 1, 2, 3). The first visit was 52 years 
old, and then 58 and 64 years old for the following two visits. The participant was a female (SEX =2). The 
baseline time was set as 0 (time = 0), and the following two exams happened on 2128 and 4192 days 
(time = 2128, 4192). The column timemifc is the time to event (MI occurred) on 3607 days counted from 
the baseline visiting time. Therefore, participant 95148 entered the study (time = 0, or period = 1) free of 
prevalent coronary heart disease (prevchd = 0). However, an MI event occurred at day 3607 following the 
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baseline examination. It means the time to event of MI for participant 95148 is 3607 days. Since she had 
the second exam at 2128 days (time = 2128, period = 2), she was free of disease (prevchd = 0, period = 
2), but before her third visit (prevchd = 1, period =3). The mi_fchd shows the participant had the event 
during the three exams (mi_fchd = 1), but it did not tell when it started. Some other participants had no 
events occurred, so they were censoring cases (prevchd = 0, mi_fchd = 0) for all three exams.  
 Example 
RANDID age SEX time period prevchd Mi_fchd Timemifc 
95148 52 2 0 1 0 1 3607 
95148 58 2 2128 2 0 1 3607 
95148 64 2 4192 3 1 1 3607 
The real data has details as shown Table 1 & Table 2) respectively. 
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Table 1   Description of data (part I) 
Variable Description Units Range or count 
RANDID Unique identification ID 2448-9999312 
SEX sex 1=male 
2=female 
5022 
6605 
PERIOD cycle 1=period 1 
2=period 2 
3=period 3 
4434 
3930 
3263 
TIME Number of days since baseline exam 0-4854 
AGE Age at exam (years) 32-81 
SYSBP Systolic blood pressure (mmHg) 83.5-295 
DIABP Diastolic blood pressure (mmHg) 30-150 
BPMEDS Use of anti-hypertensive medicine 0=not used 
1=using 
10090 
944 
CURSMOKE Current smoking 0=nonsmoker 
1=smoker 
6598 
5029 
CIGPDAY Number of cigarettes smoked per day 0=nonsmoker 
1-90 cigarettes per day 
EDUC Attained education 1= 0-11 years 
2=high school diploma 
3=vocational school 
4=college (BA, BS) above 
TOTCHOL Total cholesterol (mg/dL) 107-696 
HDLC High density lipoprotein cholesterol(mg/dL) Period 3 only 10-189 
LDLC Low density lipoprotein cholesterol(mg/dL) Period 3 only 20-565 
BMI Body mass index 14.4-56.8 
GLUCOSE Serum glucose (mg/dL) 39-478 
DIABETES Diabetic (casual glucose >= 200 mg/dL) 0=not diabetic 
1=diabetic 
11097 
530 
HEARTRTE Heart rate (beats/min) 37-220 
PREVAP Prevalent Angina Pectoris at exam 0=free disease 
1=prevalent disease 
11000 
627 
PREVCHD Prevalent Angina Pectoris at exam 0=free disease 
1=prevalent disease 
10785 
842 
PREVMI Prevalent Myocardial Infarction 0=free disease 
1=prevalent disease 
11253 
374 
PREVSTRK Prevalent stroke 0=free disease 
1=prevalent disease 
11475 
152 
PREVHYP Prevalent hypertension 0=free disease 
1=prevalent disease 
6283 
5344 
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Table 2   Description of data (part II) 
Variable name Description 
ANGINA Angina pectoris 
HOSPMI Hospitalized myocardial infarction 
MI_FCHD Hospitalized myocardial infarction or Fatal coronary heart disease 
ANYCHD Angina pectoris, Myocardial infarction, or fatal Coronary heart disease 
STROKE Atherothrombotic, Cerebral Embolism, Intracerebral hemorrhage, or subarachnoid hemorrhage 
or Fatal cerebrovascular disease 
CVD Myocardial infarction, Atherothrombotic, Cerebral Embolism, Intracerebral hemorrhage, or 
Subarachnoid hemorrhage or Fatal cerebrovascular disease 
HYPERTEN Hypertension: either Systolic >= 140 mmHg or Diastolic >= 90 mmHg at the first or second exam 
DEATH Death from any cause 
TIMEAP Number of days from baseline exam to the first Angina, 
Or number of days from baseline to censor date. 
TIMEMI Number of days from baseline exam to the first HopsMI event, 
Or number of days from baseline to censor date. 
TIMEMIFC Number of days from baseline exam to the first MI_FCHD event, 
Or number of days from baseline to censor date. 
TIMECHD Number of days from baseline exam to first ANYCHD event, 
Or number of days from baseline to censor date. 
TIMESTRK Number of days from baseline exam to first STROKE event, 
Or number of days from baseline to censor date. 
TIMECVD Number of days from baseline exam to first CVD event, 
Or number of days from baseline to censor date. 
TIMEHYP Number of days from baseline exam to first Hyperten event, 
Or number of days from baseline to censor date. 
TIMEDTH Number of days from baseline exam to first death event, 
Or number of days from baseline to censor date. 
Survival Analysis 
The purpose of current investigation is to build up a predictive model to estimate time to event for an 
individual. Due to the presence of censoring observation, the response variable will be a combination of 
time to event and indicator of censorship (time*censor).  
The censorship can be defined with indicator (as shown below formula) 
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To predict the time to event with survival data, the best and most convenient way is to identify the 
probability density function f(t) of time to event, and then its survival cumulative function S(t) and hazard 
function h(t) can be easily gotten. For example, for continuous variable time to event (t), its density 
function, 
        
    
           
  
And for survival function of time to event can be derived by, 
                                           
 
 
For its hazard function, by definition, 
        
    
               
  
 
   
    
           
  
      
 
    
    
For various survival data, different probability distributions can be selected, such as exponential 
distribution, Weibull distribution or lognormal distribution, and so on. 
For example, the probability density function of Weibull distribution, 
               
 
                  
And then its survival function and hazard function, 
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Actually, once one of the three functions is known, it will be easily to get others, since there are more 
below relations among them, 
      
     
  
                
 
  
 
                
 
             
 
However, the distribution might not be perfectly pinned down mathematically. Currently, there are three 
popular methods available for the survival data analysis. They are Kaplan-Meier nonparametric method, 
Cox proportional hazard semiparametric method, and parametric method, which is also called 
Accelerated Failure Time (AFT) model. 
 
1) Kaplan-Meier Method 
It is also called one-sample nonparametric method. Its survival function can be estimated with Kaplan-
Meier plot, Life-table, or Cumulative hazard estimator [53, 54, 56]. It is a very popular method for its 
advantages, such as, it does not require any mathematical assumption for its hazard function or 
proportional hazard. It simply takes into account with the empirical probability of surviving over certain 
time, but it assumes the value of survival function between successive distinct observations is constant. It 
is widely applied for studying survival function of population. And also, it is very commonly used to 
compare the survival functions among groups. If the sample size is large enough, its estimated survival 
function represents that of population. 
 
The method does not take into account of covariates, so it is mainly descriptive. For better presentation, 
the survival function usually shows as stepwise reduction plot. Therefore, it mainly deals with categorical 
predictors or grouped continuous variables. It cannot take care of continuous variables directly, so it will 
not be able to accommodate time-dependent variables. Even with these limitations, it is still very popular, 
because it treats censored data well, particularly right-censoring data. 
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There are two ways of estimation of survival function. One was proposed by Kaplan and Meier, the 
function is called Product-Limit estimator. It offers an efficient way of estimation its survival function for all 
the values of time (t) in the range with right censoring observations. It means before the time (t1), there is 
no event occurred, so the survival function is 1. Once the event happens, its survival function will 
decrease. The time t1 is kind of checkpoint or cutting point for event occurring. Where di is the number of 
event occurred in that time interval or at the point, and yi is the number of subject at risk in that interval or 
at the time point. It includes all subjects who have died, dropped out, or not reached the event time yet at 
that time point or interval. They are applied for all the following equations.  
 
       
      
    
  
  
    
        
  
 
Its variance estimator follows the below formula, 
 
                 
  
         
     
 
 
Since the survival function can be estimated, its cumulative hazard function can be calculated following 
formula:                . 
 
However, for data with small-sample-size, the cumulative hazard estimator can be better performed by 
Nelson-Aalen estimator. It follows the below formula: 
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Therefore, the Nelson-Aalen survival function estimator can be calculated following formula:      
           . The estimated variance for its cumulative hazard function is counted as below: 
  
      
  
   
     
The Nelson-Aalen estimator has two primary uses. The first is for selection between parametric models 
for the time to event. For example, the plot of       s time(t) is linear for exponential distribution with 
hazard rate λ. The second is in providing raw estimation of hazard rate h(t).  
Usually, the time points are assigned as small as possible.  For example, there is only one event occurred 
at that time point or in the interval. Therefore, the number of event at a particular time point or interval is 
very small. As a result, the above methods calculated survival probability at any given intervals is not 
perfectly accurate due to small number of events, but the overall probability of surviving to each time point 
is.  
To make the plot of survival function versus time, it can be achieved by        , or 
                        . 
Since the estimate of survival function and its variance can be easily counted, the confidence interval is 
also not hard to get. Basically, there are three different confidence interval can be calculated, such as 
linear confidence interval, log-transformed confidence interval, and arcsine-square root transformed 
confidence interval. Among them, the linear confidence interval is the most popular one. They are 
following the below formula respectively. 
Linear confidence interval           , where   
                     . 
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For log-transformed confidence interval 
       
          
                    
 
  
 
       
         
  
 
For arcsine-square root transformed confidence interval: 
 
                          
 
      
  
 
 
       
     
       
 
 
   
 
2) Cox Proportional Hazards Model  
The Cox proportional hazard model also is called semiparametric regression model. As discussed before, 
one of the interests of survival analysis is to compare the survival function between groups. The 
nonparametric model can do the job well if the groups are identical except one characteristic is different, 
which is what is to compare, such as treatment, or drug use, and so on. However, for most cases, the 
individuals in the data set not only vary only one, they are identified with lots of other characteristics. For 
example, the patients in current data set, subjects have demographic variables recorded, such as, age, 
sex, education, and so on. These characteristics can impact the survival function. For example, patients 
with high blood pressure will be prone to develop heart failure than the subjects with normal blood 
pressure. Therefore, it might cause severe bias if the comparison is made without consideration of these 
impacts. In addition, another goal for survival analysis is to predict the potential survival time for a 
particular subjects, ignorance of those information will leads inaccurate prediction.  
 
The Cox proportional hazards model considers both the underlying distribution of the time to event and 
the impacts of other characteristics. Therefore, for any observation, it consists of the information of triple 
             , where     is the time on the study,    is the indicator of event,    is the set of covariates for the 
ith subject. And    can be time-dependent. And 
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In general, the hazard function at time t is defined as 
               
   , 
Where                         
 
      . And the    is time-fixed variable. 
The model is called proportional hazard model, because the hazard is proportional for two subjects with 
covariates Z and Z*. It can get from the formula: 
      
       
 
                
 
   
               
      
              
   
 
   
 
Therefore, with consideration of a single covariate, for example, educational level, it has three levels. The 
relative risk for the three levels of education can be calculated by above formula. For example, level 1 as 
reference, and the relative risk of level 2 to level 1 is        , level 3 to level 1 is        , and level 3 to 
level 2 is           . 
The below are their hazard functions. 
                     
                            
                            
To test the significance of covariates on the impact of hazard in the regression, there are three tests are 
popular. They are Wald test, Likelihood Ratio test, and Score test. 
The Wald test is based on asymptotic normality of partial maximum likelihood estimate, it follows formula: 
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where    is the value under null hypothesis,  
                  is the information matrix,  
           P is the dimension of covariates. 
 
Likelihood Ratio test follows formula: 
 
   
                      
   
 
where           
 
   
 
                            
 
          
 
    
 
And Score test follows formula: 
   
       
                
       
 
where              
                
 
          
             
 
          
 
   
 
    
 
Since the semiparametric model is established with assumption of proportional hazard rate. It can be 
tested by checking variable time-dependency, or plots. To check the time-dependence of a covariate, the 
variable is modified with interaction with time (usually logarithmic transformed time), and then it is fitted 
with Cox proportional regression for its significance. 
 
In addition, the assumption can be tested graphically as well. The first method is to plot the cumulative 
hazard rate or transformed cumulative hazard rate against time with individual stratified covariate. For 
example,         
    is vector of covariate, and   
  is the remaining set (     of covariates. To test 
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whether    covariate is satisfied with proportional hazard assumption, it can be stratified into  strata. If 
the assumption holds, the baseline cumulative hazard function should be constant for each stratum.  
 
Except the assumption of proportional hazard, other aspects, such as testing of appropriate form of 
covariate in the regression, the accuracy of prediction with fitted model, and overall fitting of the final 
model. 
 
To test the best form of a covariate in the model means the functional form of a covariate can be best 
explained its effect on survival through the proportional hazard model, for example, log, quadratic,  
square, and so on. To find out the best form of a covariate, the martingale residual plot is applied. It has 
the following form, 
                     
             
 
 
 
where        
                                                
                       
                             
                                 
   
                                                                       
                                                                                     
                                                                                 
                                                            
                                               
To build the plot, the Cox proportional hazard regression is fitted with the     covariates (  ) except the 
one being tested (   . Its function is to be determined 
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Then the martingale residuals are computed, and plotted against the tested covariate. The       can be 
determined by it shape, for example, linear means no need for transformation. 
 
To test the overall fitting of the final regression model, the Cox-Snell residual plot is applied. In principle, 
suppose the proportional hazards model:                           is correctly fitted, if the probability 
integral transformation on the true death time  , then the resulting random variable           has an 
exponential distribution with hazard rate 1. Therefore, if the model is correct, and   
  will be close to true 
 , then the residual      will look like a censored sample from a unit exponential distribution. The formula 
of    is defined as: 
                   
                      
 
   
 
 
where                   
                                      
              
                                
                                                    
To check whether    behaviors as from a unit exponential distribution, the Nelson-Aalen estimator of 
cumulative hazard rate is calculated by following the below formula, and then a plot of    versus     . If 
the model is fitted well, it should be a straight line through the origin. 
 
      
                    
 
  
  
    
                 
  
 
3) Accelerated Failure Time Model 
Accelerated failure time model (AFT model) is a parametric model for estimating univariate survival and 
for censored-data regression problem. For nonparamatric model, it estimates the survival function based 
on the observation only. It does not require any distribution of the data. However, the question may 
become much simpler if the data fits a distribution well, since there are fewer parameters should be dealt 
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with. The AFT model means that the survival function of an individual with covariate Z at time t is the 
same survival function of an individual with a baseline survival function at a time          , where θt is a 
vector of regression coefficients. It means, 
 
               
                       
 
where           is called an acceleration factor. It means how a change in covariate alters the time scale 
from the baseline time scale. It implies that the median time to event with covariate Z is the baseline 
median time to event divided by its acceleration factor. Similarly, the hazard function is also able to be 
calcualted. It is also related to the baseline hazard rate. 
 
               
                               
 
Furthermore, from the above implications and presentations, the logrithmatic transformed time has linear 
relationship with covariate values (as shown below). 
 
               
 
where    is a vector of regression coefficients, and  is the distribution for error. To identify the survival 
function of T, it can be followed by:                                        
    
         
 
     
         
 
  
           
Since  follows a paticular distribution, its survival function is known with time equaling to 
         
 
 . 
Therefore, the mean time or mean residual life time can be estimated by the model. The maximum 
likelihood estimation is applied for estimating the parameters for thee models. While their vaiance-
covaraince matrix may be obtained by delta method.  
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To select a model, the transformed Nelson-Aalen estimated cumulative hazard function is plotted against 
some function of time. For example, Weibull distribution, its cumulative hazard rate can be expressed as: 
   , so there is a linear relationship for a plot with         . While for exponential distribution, its 
cumulative function is   , so the plot      will be a straight line through th origin. Its slope will be the 
parameter  . Therefore, if the linearality does not hold, it means the parametric model does not fit the 
data. When comparing two groups, the q-q plot is usually applied for checking whether the model fits data 
well. For example,    and    are survival function of group 1 and group 2, then  
 
                
 
where   is accerelation factor. 
And the following will hold as well, since       
              
 
                               ,  
 
where    ,    are the p-th quantiles of groups 0 and 1 respectively. 
 
 
Tests for Significance 
For hypothesis test, the threshold for significance is of P-value at 0.05. The test for significance for others 
is listed in their respective chapters.  
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Methods and Procedures 
                          
SAS Procedures  
SAS 9.1.3 statistical package is applied for the current data analysis. In SAS, Proc LIFETEST, LIFEREG 
and PHREG are three major procedures for survival analysis. In general, Proc LIFETEST is used to 
compute nonparametric estimates of the survival function by Kaplan-Meier method. Since we are 
interested in estimating the survival distribution function (SDF), the Kaplan-Meier plot can represent its 
survival function if the sample size is big enough. In addition, the Proc LIFETEST is also applied for 
making plots to compare survival curves among groups. The procedure offers Log rank test to evaluate 
significance of difference. 
 
The Proc PHREG is applied for performing regression analysis of survival data based on the Cox 
proportional hazards model. To build up the predictive model for hazard function, the Proc PHREG is 
applied for model selection using option of stepwise. Based on the same strategy, the model is improved 
by taking into account of interaction terms. And then, the model is finalized by backward method by 
eliminating the predictors with the least significance or the highest p-value step by step. The procedure is 
also applied to test time dependence of variables, generate residual plots for model fitting diagnostics, 
survival functions plots for comparison between groups. 
 
The Proc LIFEREG is applied to fit parametric models for the failure time to events. It is also called the 
accelerated failure time model. In our current study, it is used for assessment of effectiveness of variables 
selected by Cox proportional hazards model. To fit the model, the failure time is logarithm transformed, 
and Weibull distribution is specified for disturbance term.   
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Results 
Data exploration 
First of all, information of current data set is shown in Table 3. It has 11627 observations. There are 
continuous variables, such as totchol, age, sysbp, diabp, cigpday, bmi, heartrte, glucose, and variable for 
time to event or censoring (timeap, timemi, timemifc, timchd, timestrk, time cvd,  timedth, timehyp). The 
discrete variables are sex, cursmoke, diabetes, bpmeds, educ, and indicators for events, such as death, 
angina, hospmi, mi_fchd, anychd, stroke, cvd, hyperten. In addition, there are numbers of missing values 
for variables totchol, cigpday, bmi, bpmeds, glucose, and educ. In the current study, the missing values 
are removed for complete case analysis.  
   
                  
Table 3    Data summary 
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Before the analysis, some definitions need to be clarified. First, the events recorded in current data 
include death, angina, hospmi, mi_fchd, anychd, stroke, cvd and hyperten. The death is cardiovascular 
diseases related or unrelated. The disease unrelated death is treated as censoring. For disease related 
death and other events are indications for onset of cardiovascular diseases, since the diseases will be 
realized sooner or later with onset these intermediate symptoms. Therefore, if any of the above events 
happens for an observation, the event for the observation is recorded as realized observation. Otherwise, 
they are treated as censored observations. Second, the time to event is recorded the period starting from 
baseline to the time of end of investigation, time of dropout, death, or minimum time to any of events. 
Third, to better investigate the impacts of variables on disease onset, the subjects with preconditions are 
removed before conducting analysis. Finally, since it is a longitudinal data set, to simplify or decrease the 
impact of time-serials, the final data set only includes observations at period 1. In another word, the study 
shows how the survival function is influenced by the conditions, such as age, biochemical measurements 
and so on at that time. 
 
Overall, there are 949 censored observations (censor=0), and 1937 observations with events (censor=1). 
 
         
 
Model Selection 
The goal of current investigation is to identify risk factors of cardiovascular diseases, and their effects on 
the contribution to the onset and progression of the diseases. To determine the variables included in the 
final model, the univariate analysis is applied first to identify the impact of individual variable on time to 
event before proceeding more complicated model selection. For the categorical variables, such as sex, 
smoking status (cursmoke), education level (educ) and status of diabetes (diabetes), the non-parametric 
model Kaplan-Meier curves are generated (as shown Figure 1). And the significance of impact is tested 
by log-rank test individually, and summarized in Table 4. The log-rank test is better than Wilcoxon test, 
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since it is more sensitive for difference happens at the late stage. In addition, the log-rank test will not 
generate bias when the pattern of censoring is different between groups. The data indicates that the 
variable sex, diabetes and educ could be potential risk factors for the model. Since their p-values are less 
than 0.0001, which is far below the threshold of significance at 0.05. However, the p-value for variable 
cursmoke is over 0.6245, so it will not be included for final model. In addition, the survival curves for all for 
variables, such as sex, diabetes and cursmoke, do not cross over groups. The educ level 1 behaviors 
differently from other three levels, so the three can be treated as one single group for fitting the model 
with satisfactory to the assumption of proportional hazard rate. Therefore, they can be potential to fit 
proportional hazard model.  
 
 
 
For the continuous variables, the univariate analysis is performed by Cox proportional hazard regression. 
To include the potential predictors in the final model, the threshold to keep the variable for model 
selection with p-value equal to or less than 0.2 – 0.25, just in case that they may contribute to the impact 
on disease onset or progression with other predictors.   
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In our current study, variables, such as totchol, age, sysbp diabp, bmi and glucose have significant impact 
on disease onset with p-value less than 0.0001 individually. Although the variable cigpday has p-value at 
0.106, it will be kept for model selection since its p-value less than 0.25. The p-value for variable heartrte 
is 0.2876, which is over the threshold for our model selection, but it is a very important predictor, so it will 
be included for model selection as well. As reported, coronary mortality rates increased progressively in 
relation to antedent heart rates, especially for male patients of 35 to 64 years of age [76]. The outcomes 
for the Cox proportional hazard analysis for the individual variables are summarized as shown (Top, 
Table 4). Therefore, variables sex, educ, diabetes, totchol, age, sysbp, diabp, bmi, glucose and heartrte 
are kept for model building. 
 
 
 
Table 4   Univariate analysis 
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For the following process of model building, the above variables with p-value less than 0.25, except 
heartrte are included. Since variable educ has four levels, it is included for model selection using the sub-
group educ = 1 as the reference group. To further confirm its significant impact on disease onset or 
progression, the procedure proportional hazards regression is applied for the test. The data shows its p-
value is 0.0116, which is less than the threshold of significance with p-value at 0.05 (Table 5). It indicates 
that the variable should be included in the predictive model. As shown above, the education level is 
categorized into two levels: level 1, and combined levels above 1, and then the assumption of 
proportional hazard rate can be satisfied. 
 
 
 
To select the best subgroup of variables in our model, the approach of stepwise was applied in SAS 
procedure PHREG. The stepwise selection process consists of a series of alternating forward selection 
Table 5   Significance test for variable: educ 
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and backward elimination steps. The former step adds variables into the model, and the latter step 
removes variables from the model. The threshold for variable selection into the model is setting with p-
value at 0.25 (SLENTRY = 0.25), while the threshold for variable removing from the model is setting with 
p-value at 0.15 (SLSTAY = 0.15). It means only variables with p-value less than 0.25 will be tested in the 
model, and to keep it in the model, its p-value should be less than 0.15. The results from the stepwise 
proportional hazard regression are displayed as below (Table 6). According to the settings, variables such 
as sex, age, totchol, sysbp, diabp, cigpday, bmi, diabetes, glucose and educ are included in the raw 
model. Their significances on the impact in the model can be found in column named Pr > ChiSq in the 
following table. The value is estimated by analysis of maximum likelihood estimation. And the effects for 
individual predictors in the model are shown in column named Parameter Estimate. The data shown 
predictors such as sex and educ have negative impact on hazards rate. It indicates that females have 
lower hazard than males. And higher educated people have lower hazard than lower educated patients 
do. Since there are variables with non-significant p-values, the model should be able to be improved by 
elimination of the variables with the largest p-value one by one.  
 
 
 
Table 6   Raw variables selected by Stepwise  
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To further optimize the Cox model, the variable with the highest p-value and over threshold of significance 
are removed from the predictive model one by one until all the rest variables are shown significant impact 
on the prediction of hazard rate. From Table 3, the variable called glucose is the one with highest p-value, 
so it is removed according to our strategy in the following regression test. The result is shown as below 
(Table 7).  
 
 
 
And then, the same strategy is applied for the following analysis. The variable called diabp is removed in 
the following step although the p-value of totchol is higher than it, since there is another parameter called 
sysbp is included. The data shows that most of the predictors are significant in the model with their p-
value less than 0.05 or close to 0.05. The data is shown as below (Table 8). 
 
 
 
 
 
 
Table 7   Step 2 elimination variable with high p- value by Stepwise  
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Since the predictors might interact with each other for prediction in the model. To test the interaction 
among variables, the list of all raw variables and all possible combinations of interactions are included for 
proportional hazard regression analysis. To select the interaction terms, same strategy is applied. The 
result is shown as below (Table 9). From the table, interactions such as sex_age, totchol_cigpday, 
totchol_bmi, age_educ, sysbp_diabp and diabetes_glucose might impact on the prediction according to 
their p-values, which are shown in columns called parameter estimate and Pr > ChiSq respectively. 
Table 8   Step 3 elimination variable with high p- value by Stepwise  
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To test how good fit including all originally selected variables and the potential interaction terms, all of 
them are included for the proportional hazards regression analysis. In general, total variables in the list 
are sex, totchol, age, sysbp, cigpday, bmi, diabetes, educ, diabp, glucose, sex_age, totchol_cigpday, 
totchol_bmi, age_educ, sysbp_diabp and diabetes_glucose. Since the significant impact of some 
interaction terms involve some variables, which are not significant and removed in the initial process of 
model optimization, such as diabp and glucose, they are reintroduced in the process of model selection.  
The data shows that some terms are not significant when all possible predictors are included, such as 
educ, diabetes_glucose, whose p-value are 0.8571 and 0.8205 respectivly. And the effect of variable sex 
is shown negative impact. It makes sense, since the female has less risk than male patients suffering 
from the cardiovascular diseases. However, the model needs to be further optimized, because some 
variables in the raw model are not significant enough. The detail can be found as below (Table 10). 
Table 9   Interaction terms selected by stepwise 
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As before, to further optimize the predictive model, the variable with the highest p-value is removed from 
the regression analysis. In current case, the interaction term called diabetes_glucose is removed first, 
though it has lower p-value than that of educ, because the glucose is not found significant impact on the 
prediction at the first place. The result of regression is displayed as below (Table 11).  
Table 10   Raw Final Model with Interaction Terms  
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Based on the same strategy, the interaction term called educ_age is removed from the following 
regression analysis, since it has the highest p-value at 0.9147 (Table 12).  
 
Table 11   Optimize Final Model with Interaction Terms_1 
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And then the predictor called diabp and sex_diabp are removed from the following regression as shown 
(Table 13).  
 
Table 13   Optimize Final Model with Interaction Terms_3 
Table 12   Optimize Final Model with Interaction Terms_2 
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Similarly, the variable sex_sysbp is removed from the following regression (Table 14). Eventually, the final 
model is generated including variable sex, totchol, age, sysbp, cigpday, bmi, diabetes, educ, sex_age. 
However, the effect of sex has positive impact on the cardiovascular diseases. It is opposite to the well-
known fact that female risks less than male on cardiovascular diseases. The effect of gender might be 
influenced by introducing the interaction terms such as sex_age, sex_sysbp. 
 
 
 
Validation of Assumption of Proportionality 
The final model is built based on a major assumption that the hazards between groups are proportional. 
To test the assumption of proportionality, two common methods are widely applied. It can be achieved 
either by generation of Kaplan-Meier Curve                         ) using Proc LIFETEST, or testing 
the time dependence for time dependent variables.  If the assumption of proportionality is established, the 
Kaplan-Meier curves between groups are parallel, or the effects of time dependent variables on prediction 
are not varied with time. The Kaplan-Meier curves are usually applied for categorical variables, or 
continuous variables that can be easily grouped. They can be produced in the Proc LIFETEST model 
Table 14   Optimize Final Model with Interaction Terms_4 
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statement using survival density function      Vs time    , or                           . In our current 
study, the logarithm transformed time and survival function is applied. For continuous variables, the 
model can include time dependent variables instead, which are interactions between logarithm 
transformed time and variables. It can be tested in Proc PHREG directly.  
 
Our data show categorical variables such as sex, diabetes and education level are proportional in the 
model using plot of                           . For variable:educ, the proportional hazard function is 
more obvious when the comparison between level 1 and combination of level 2,3 &4 (As shown in Figure 
2).  
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However, the overall proportionality of the final model for the continuous variables is not observed, since 
the overall p-value is less than 0.0001 (Table 15). Particularly, the time dependence is from variables 
age, sex_age and cigpday, which have p-value < 0.0001, 0.0083, 0.0005 respectively (Table 12).  
 
 
 
To improve the performance of the model, these three variables are transformed into time dependent 
form (x*log(t), x: variable, t: time to event) and applied for fitting the model instead of the original ones. 
And then, the new model is verified again by proportional regression to test its proportionality. The results 
Table 15   Test for proportional assumption 
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show that the assumption of proportionality for continuous variables sysbp and bmi  holds, since the p-
value for overall test is 0.4068, and for sysbp and bmi are 0.7787 and 0.254 respectively (Table 16). 
 
 
 
 
Model Optimization 
To further optimize the final model by fitting the three transformed time dependent variables instead of 
original variables, the model including sex, totchol, sysbp, bmi, diabetes, educ, ageT, sex_ageT and 
cigpdayT is fitted with proportional hazards regression analysis. The result shows that the variable 
sex_ageT is not a significant variable anymore with p-value at 0.1546 (Table 17). 
 
Table 16   Test for proportional assumption-2 
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To solve the problem, the variable sex is stratified to fit the model, and the regression is redone, and it 
shows all the variables fit the model significantly (As shown Table 18) eventually. The results indicate that 
sex should be considered as a dominated predictor in the model. Therefore, it can be analyzed by its 
stratification. It means that the observations from different genders should be analyzed separately with 
their own baseline hazards rate. Overall, the model fits the observations in the data.  
 
 
Table 18   Final model with time-dependent variable and stratified variable: sex 
Table 17   Raw final model with time-dependent variable 
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In summary, the final proportional hazard function model is finalized with formula: 
 
                                                                               
                                                      
                                                                                    
                                                                                     
 
 
 
                                                                               
                                                      
                                                                                    
                                                      
 
Where female and male have their own baseline hazard functions. The model satisfies the assumption of 
proportionality for all categorical variables, such as diabetes, sex and educ, and partial continuous 
Table 19   Stratification with variabel: Sex 
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variables such as bmi and sysbp. However age, cigpday and sex_age behavior in a time-dependent 
manner. However, the age changes with the time, so it should be treated as a fixed covariate. Certainly, 
the sex_age should be treated as a fixed covariate as well, since sex never changes over time. In another 
word, the time-dependent variable is cigpday only. Therefore, the model is suitable to predict the time to 
event by using subject with fixed certain measurements or characteristics, but more considerations 
should be taken to make more precise prediction if time-dependent covariates are presented.  
 
Model Diagnostics 
To test how good fit the model with these predictors overall, the diagnostics is performed by measuring 
the deviance residual plots. In SAS, the option Resdev is applied for the measurements. The plots for the 
all linear predictors or individual predictor show that the majority of the residuals are converged around 
the baseline, and distributed almost evenly over their respective ranges. Certainly, there are outliers 
observed in the plots, but overall, the fitting is good (Figure 3).  
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                                                                  Figure 3 
 
Comparison of Survival Functions 
Since the model fits well with the set of covariates, their survival function is also analyzed individually by 
fixing values for all the rest variables. The data is shown below (Figure 4). From the figure, the survival 
function for male subjects with older age, higher body mass index, more smoking, status of diabetes, 
lower education level, higher value for the combination between sex and age, higher level of total 
cholesterol, or and higher blood pressure will decrease quicker than those of subjects with opposite 
characteristics and measurements. However, the effects observed from the survival density function 
match the parameter estimated from proportional hazards function model by regression analysis. 
Therefore, the model is good.  
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Parametric model 
As discussed, a better parametric model will make the estimation of survival function much simpler, since 
it deals with much less parameters. To test this, the same above selected set of covariates are applied to 
fit the regression. To fit the model, the logarithmic transformed time (t) has the equation with error term 
(w) following certain distribution, and determined by set of covariates. Its formula is 
              . Therefore, its survival function is                                
            
         
 
     
         
 
   The output is shown in Table 20. Therefore, the 
estimated logarithmic transformed time to event is influenced significantly as the formula shown:  
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To test the overall model fitting, the Cox-snell residual plot is generated. If the model is correct. It means 
     , the Cox-snell residual should look like a censored sample from an exponential distribution. And 
then, the plot of              should be an approximate straight line through the origin with slope of 1. As 
expected, it should be a straight line going through the origin. In general, the line is close to straight one, 
but it is not perfect. It indicates that the model should be able to further be improved. The martingale 
residual plot is produced with residual versus time. Overall, it is smooth over time. The Schoenfeld 
residual is computed for each covariate and each individual, if the assumption of proportional hazard 
holds, the chance of failure at the      individual at time    given there is one death at    is: 
  
   
   
       
, 
where                                                         And the Schoenfeld residual is defined as: 
                                                                 
                                                                                         Therefore, for 
each individual I, there are a set of values, one for each covariate j included in the PH model. If the PH 
Table 20   AFT: Analysis of Parameter Estimates 
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assumption is correct, thee Schoenfeld residuals are uncorrelated with mean 0. The Schoenfeld residual 
plot is very smooth, and is converged around the baseline. The deviance residual plot is used to check 
the model fitting of individual observations. And it is good for finding outliers. The deviance residual is 
defined as: 
                                  
 
                                   
There are considerable observations are seen as outliers in the model. Therefore, the model needs 
further improvement. 
 
 
To improve the model fitting, two ways can be tried. First is to add more data, and/or include more 
covariates, but it may be too costly. And sometimes, it is not feasible. Second is to optimize the model by 
fitting with different transformed forms of covariates. To test whether the forms of covariates in current 
model is the best or not, the martingale residual plots against respective covariates are generated (as 
Figure 4 
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shown in Figure 5). The lines seem to be smooth, but the forms applied in the model, majority of the 
covariates, such as totchol, sysbp, cigpday, bmi and sex_age are not perfect.  
 
 
The model fitting is further checked by Q-Q plot (as shown in Figure 6). As expected, the true fitting 
means the plot is a straight line going through the origin with slope of 1. From the data, the sex fits the 
model perfectly. The covariate diabetes does not fit the model well at all. The variable educ only fits the 
model well before survival time of 6000 days. Therefore, the diabetes covariate should be optimized by 
Figure 5 
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some way. The sysbp is a continuous variable. In the figure, it is categorized with breaking point at 
140mmHg, to show high blood pressure and normal blood pressure. The form is not perfect as well. 
 
 
To test which model fits the data the best, the log likelihood ratio of four popular distributions for 
estimating survival curve is calculated from SAS. And their respective AIC values are calculated based on 
the values of log likelihood ratio (as shown in Table 21). The result indicates that Weibull distribution is 
the best model fitting the data, since its AIC value is the least. 
Figure 6 
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Discussion 
The cardiovascular diseases are the leading causes of death world-wide. To figure out how the diseases 
are occurred, many efforts have been paid. Thus far, many factors have been found association with 
onset or progression of the diseases [11]. They are called risk factors, such as gender, sex, smoking 
status, blood pressure, blood total cholesterol and diabetes, and so on [11, 12]. To better understand their 
impacts of individual risk factors on the onset or progression of the diseases, many scoring systems or 
models have been built for measuring their effects, such as Framingham Scoring System, European 
Systematic Coronary Risk Evaluation algorithm (SCORE), and the Prospective Cardiovascular Munster 
(PROCAM) model. In general, the systems assign values for individual risk factors, and then add them up 
for individual subjects [30, 31, 32, 34]. The higher score a subject has, greater risk for suffering from 
cardiovascular diseases will be. These scores are assigned arbitrarily. And also, the scoring systems are 
built based on specific populations. Therefore, great variations are usually observed across populations 
by applying same system or model. Even within same population, much variation is also observed from 
different cohorts [31, 36, 39]. Thus far, most models have not been cross validated with different cohorts. 
Therefore, it is still far away from applicable for any system or model to a general population. 
Our current investigation is trying to build up a predictive model based on subset of Framingham Heart 
Study dataset by survival analysis. It has been widely used various fields, such as, biomedicine, 
engineering, social science, and so on. The survival analysis is specially designed for investigating 
survival data. Its features of censoring and non-normality generate huge difficulty in analyzing the data by 
traditional statistical models or methods. The non-normality aspect of the data violates the normality 
Table 21   Comparisons among models with different distributions 
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assumption of most commonly used statistical models such as regression or ANOVA, and so forth. And 
censoring is very popular in survival data. It means the information of such observation is incomplete. In 
general, there are five different censorings observed in survival data: right truncation, left truncation, left 
censoring, right censoring and interval censoring. In the current dataset of Framingham Heart Study, only 
right censoring is observed. It can be several reasons, i.e. drop out of the investigation, or termination of 
the investigation, or death because of event unrelated reasons [52, 53, 54]. Therefore, any subject either 
experiences an event at some time point, or survives over the time point (censoring). 
Another feature for survival analysis is the hazard rate. For discrete time the hazard rate is the probability 
that an individual will experience an event at time point t. Therefore, the hazard rate is just the estimated, 
unobserved rate. It can be constant or vary with time [54]. 
To build up the model, the univariate analysis is conducted to test the association between variable and 
the time to even [61]. The Kaplan-Meier plots are generated for each categorical variable for the purpose. 
However, the univariate analysis is tested by Cox proportional hazards regression. The threshold to keep 
variable for further model selection is p-value below is 0.25. Interestingly, the education seems to be 
involved in impacting on onset or development of cardiovascular diseases. It makes sense somehow, 
since people have different lifestyles with different educations, such as, physical activity, friends cycles, 
food, and so on [13, 16].  
Sex is a significant covariate as well. It is a commonly sense, since females usually have much less 
chance suffering from cardiovascular diseases than male. When Cox proportional hazard model is built, 
its performance is strikingly different from others, so it is treated as stratification. 
Other factors, such as high blood pressure, total blood cholesterol, body mass index, and age are well 
known disease-related risk factors. It is not surprising to see their positive influences on the disease onset 
and development. In another words, the higher values of them are, the survival time will be shorter, while 
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the hazard rate will be higher. The results can be seen in the estimates of parameter in semiparametric 
model and parametric model. 
Current model includes two time-dependent variables, such as age, number of cigarettes smoked 
(cigpday). It indicates that the risk of suffering from cardiovascular diseases will increase with aging. It is 
well known that the heart undergoes subtle physiologic changes as person gets older, even without the 
diseases. It means impacts of diseases of these two variables can be additive to the influence of aging. 
Interestingly, in our current hazard model, interaction between sex and age is observed with positive 
impact on life time. It is understandable for sex, but age does not make too much sense. Therefore, the 
impact may mainly contribute from the gender for the interaction, since one unit change of gender (from 
male to female: 0 to 1) means lots of age change.  Another interesting explanation is that if subjects do 
not have cardiovascular diseases when they are old, they must have good genetics [14, 19].  
Overall, the model fits the dataset well although it is not perfect. It can be visualized from the deviance 
residual plots. But it is still able to be improved by adding more data, or optimized by change the form of 
the covariates. 
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